Moderna, Inc. — Director's Dealing 2020

Sep 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-09-14

Reporting Person: Hoge Stephen (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-14	Common Stock	M	10000	$.99	Acquired	1956530	Direct
2020-09-14	Common Stock	S	11150	$60.24	Disposed	1945380	Direct
2020-09-14	Common Stock	S	1203	$61.96	Disposed	1944177	Direct
2020-09-14	Common Stock	S	4784	$62.78	Disposed	1939393	Direct
2020-09-14	Common Stock	S	2863	$63.54	Disposed	1936530	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-14	Stock Option (Right to Buy)	$.99	M	10000	Disposed	2023-08-19	Common Stock (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4116	Indirect

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on June 1, 2020.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.15 to $61.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.23 to $62.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.25 to $63.24. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.28 to $63.84. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: This option is fully vested and exercisable.